These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10618309)

  • 21. Frequency dependence in the action of the class III antiarrhythmic drug dofetilide is modulated by altering L-type calcium current and digitalis glucoside.
    Gjini V; Schreieck J; Korth M; Weyerbrock S; Schömig A; Schmitt C
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):95-100. PubMed ID: 9456283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The electrophysiological effects of racemic ketamine and etomidate in an in vitro model of "border zone" between normal and ischemic/reperfused guinea pig myocardium.
    Hanouz JL; Repesse Y; Zhu L; Lemoine S; Rouet R; Sallé L; Plaud B; Gérard JL
    Anesth Analg; 2008 Feb; 106(2):365-70, table of contents. PubMed ID: 18227286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes.
    Kiehn J; Villena P; Beyer T; Brachmann J
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):566-72. PubMed ID: 7528839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Res; 1992 Nov; 26(11):1109-15. PubMed ID: 1291089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers.
    Lu HR; Mariën R; Saels A; De Clerck F
    J Cardiovasc Electrophysiol; 2001 Jan; 12(1):93-102. PubMed ID: 11204092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block.
    Ohler A; Amos GJ; Wettwer E; Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):602-10. PubMed ID: 7969512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental changes in IKr and IKs contribute to age-related expression of dofetilide effects on repolarization and proarrhythmia.
    Obreztchikova MN; Sosunov EA; Plotnikov A; Anyukhovsky EP; Gainullin RZ; Danilo P; Yeom ZH; Robinson RB; Rosen MR
    Cardiovasc Res; 2003 Aug; 59(2):339-50. PubMed ID: 12909317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dofetilide, a novel class III antiarrhythmic agent.
    Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusion.
    Alexandre J; Beygui F; Puddu PE; Manrique A; Rouet R; Milliez P
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):313-21. PubMed ID: 25389106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
    Martin CL; Palomo MA; Mcmahon EG
    J Pharmacol Exp Ther; 1996 Jul; 278(1):154-62. PubMed ID: 8764346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proarrhythmic and antiarrhythmic effects of bupivacaine in an in vitro model of myocardial ischemia and reperfusion.
    Picard S; Rouet R; Flais F; Ducouret P; Babatasi G; Khayat A; Potier JC; Bricard H; Gérard JL
    Anesthesiology; 1998 May; 88(5):1318-29. PubMed ID: 9605693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits.
    Pham TV; Sosunov EA; Anyukhovsky EP; Danilo P; Rosen MR
    Circulation; 2002 Oct; 106(16):2132-6. PubMed ID: 12379585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers.
    Gillis AM; Mathison HJ; Kulisz E; Lester WM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):381-6. PubMed ID: 10604974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1999 Sep; 81(1):79-85. PubMed ID: 10580374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.